Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, toxicity and quality of life-Reference-Cited by-同舟云学术

Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, toxicity and quality of life

Published:2021-08 Issue: Volume:161 Page:40-46
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Musunuru Hima Bindu,Cheung Patrick,Vesprini Danny^ORCID,Liu Stanley K.^ORCID,Chu William,Chung Hans T.,Morton Gerard,Deabreu Andrea,Davidson Melanie,Ravi Ananth,Helou Joelle,Ho Ling,Zhang Liying^ORCID,Loblaw Andrew^ORCID

Funder

Prostate Cancer Canada

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference35 articles.

1. Brachytherapy for patients with prostate cancer: American Society of Clinical Oncology/Cancer Care Ontario Joint Guideline Update;Chin;J Clin Oncol,2017

2. Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life;Morton;Int J Radiat Oncol Biol Phys,2010

3. Results of 15Gy HDR-BT boost plus EBRT in intermediate-risk prostate cancer: analysis of over 500 patients;Martell;Radiother Oncol,2019

4. Tumor focality in prostate cancer: implications for focal therapy;Karavitakis;Nat Rev Clin Oncol,2011

5. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence;Pucar;Int J Radiat Oncol Biol Phys,2007

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enteric α-Defensin Contributes to Recovery of Radiation-Induced Intestinal Injury by Modulating Gut Microbiota and Fecal Metabolites;Radiation Research;2023-12-21

2. Safety of Ultrahypofractionated Pelvic Nodal Irradiation in the Definitive Management of Prostate Cancer: Systematic Review and Meta-analysis;International Journal of Radiation Oncology*Biology*Physics;2023-10

3. Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institution trial;Clinical and Translational Radiation Oncology;2023-05

4. Two-fraction stereotactic ablative radiotherapy with simultaneous boost to MRI-defined dominant intra-prostatic lesion – Results from the 2SMART phase 2 trial;Radiotherapy and Oncology;2023-04

5. Acute and Late Adverse Effects of Prostate-Only or Pelvic Stereotactic Radiation Therapy in Prostate Cancer: A Comparative Study;International Journal of Radiation Oncology*Biology*Physics;2022-10